Literature DB >> 16368294

The impact of ejection fraction on outcomes after percutaneous coronary intervention in patients with congestive heart failure: an analysis of the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry and Dynamic Registry.

Elizabeth M Holper1, John Blair, Faith Selzer, Katherine M Detre, Alice K Jacobs, David O Williams, Helen Vlachos, Robert L Wilensky, Paul Coady, David P Faxon.   

Abstract

BACKGROUND: Patients with congestive heart failure (CHF) have higher rates of adverse outcomes after percutaneous coronary intervention (PCI). A comprehensive analysis of outcomes in patients with CHF in the current era has not been done. We studied the outcomes of patients with CHF who underwent PCI in the National Heart, Lung, and Blood Institute-sponsored Percutaneous Transluminal Coronary Angioplasty (PTCA) and Dynamic registries.
METHODS: We evaluated demographic and angiographic characteristics and the clinical outcomes of patients with CHF in the Dynamic Registry and the PTCA Registry, excluding patients with acute myocardial infarction. In the Dynamic Registry, patients with CHF (n = 503) were compared with patients without CHF (n = 4194), and patients with CHF with a preserved ejection fraction (EF) (n = 134) were compared with patients with CHF who have a reduced EF (n = 199). The patients with CHF in the 1997 through 2001 Dynamic Registry (n = 236) were then similarly compared with patients with CHF in the earlier PTCA Registry (n = 117).
RESULTS: In the Dynamic Registry, compared with patients without CHF, patients with CHF had a higher-risk clinical and angiographic profile, and a higher mortality rate both inhospital (2.6% vs 0.4%, P < or = .001) and at 1 year (13.1% vs 3.0%, P < .001). Patients with reduced EF had higher inhospital mortality rates and a trend toward higher mortality at 1 year. The patients with CHF in the Dynamic Registry compared with those in the PTCA Registry had a higher risk profile yet had significantly higher procedural success rates and improved clinical outcomes.
CONCLUSIONS: Although CHF remains a strong predictor of adverse outcomes after PCI, significant improvement seen in the past decade is likely related to improved procedural techniques and improved medical therapy.

Entities:  

Mesh:

Year:  2006        PMID: 16368294     DOI: 10.1016/j.ahj.2005.03.053

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

1.  Risk guided use of the direct thrombin inhibitor bivalirudin: insights from recent trials and analyses.

Authors:  William B Hillegass; Gregory S Bradford
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

2.  Characteristics and in-hospital outcomes of hospitalisations with heart failure with reduced or preserved ejection fraction undergoing percutaneous coronary intervention.

Authors:  Rajkumar Doshi; Krunalkumar Patel; Neelesh Gupta; Rajeev Gupta; Perwaiz Meraj
Journal:  Ir J Med Sci       Date:  2018-10-16       Impact factor: 1.568

3.  Evolving approaches to the management of heart failure with preserved ejection fraction in patients with coronary artery disease.

Authors:  Sanjiv J Shah
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-01

4.  Systolic dysfunction portends increased mortality among those waiting for renal transplant.

Authors:  Angelo M de Mattos; Andrew Siedlecki; Robert S Gaston; Gilbert J Perry; Bruce A Julian; Clifton E Kew; Mark H Deierhoi; Carlton Young; John J Curtis; Ami E Iskandrian
Journal:  J Am Soc Nephrol       Date:  2008-03-27       Impact factor: 10.121

5.  Predictors of long-term survival in acute coronary syndrome patients with left ventricular dysfunction after percutaneous coronary intervention.

Authors:  Doo Hwan Lee; Myung Ho Jeong; Jung Ae Rhee; Jin Su Choi; Ki Hong Lee; Min Goo Lee; Doo Sun Sim; Keun-Ho Park; Nam Sik Yoon; Hyun Ju Yoon; Kye Hun Kim; Hyung Wook Park; Young Joon Hong; Ju Han Kim; Youngkeun Ahn; Jeong Gwan Cho; Jong Chun Park; Jung Chaee Kang
Journal:  Korean Circ J       Date:  2012-10-31       Impact factor: 3.243

Review 6.  Hospitalisation costs associated with heart failure with preserved ejection fraction (HFpEF): a systematic review.

Authors:  Hannah Clark; Rezwanul Rana; Jeff Gow; Melissa Pearson; Tom van der Touw; Neil Smart
Journal:  Heart Fail Rev       Date:  2021-03-25       Impact factor: 4.214

7.  Left Ventricular Pressure Ratio Predicts In-Hospital Outcomes in Hospitalized Heart Failure With Reduced Ejection Fraction.

Authors:  Sameh W Almousa; Mark N Belkin; Tess Allan; Allison Stephens; Joseph Kern; Miryea Cisneros; Janet Friant; Cynthia Arevalo; Sandeep Nathan; Atman P Shah; Jonathan Paul; Rohan Kalathiya; Jonathan Grinstein; John E A Blair
Journal:  J Invasive Cardiol       Date:  2021-06-16       Impact factor: 2.022

8.  Impact of Chronic Kidney Disease on Long-Term Outcome in Coronary Bypass Candidates Treated with Percutaneous Coronary Intervention.

Authors:  Jian-Rong Peng; Chi-Jen Chang; Chun-Li Wang; Ying-Chang Tung; Hsin-Fu Lee
Journal:  Korean Circ J       Date:  2016-12-12       Impact factor: 3.243

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.